ZOMDF
Zomedica Corp.
Key Financials
Gross Profit
$21.7M
↑ 13.6%
Revenue
$32.0M
↑ 17.4%
Operating Income
$-84353000
↓ 65.2%
Net Income
$-81858000
↓ 74.2%
Total Assets
$127.0M
↓ 38.7%
EPS (Diluted)
$-0.08
↓ 60.0%
Shareholders' Equity
$115.4M
↓ 41.0%
Cash & Equivalents
$9.0M
↑ 28.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 5/14/2026 | View on SEC |
| 4 | 5/11/2026 | View on SEC |
| 4 | 5/8/2026 | View on SEC |
| 8-K | 5/6/2026 | View on SEC |
| 10-Q | 5/6/2026 | View on SEC |
| DEF 14A | 4/27/2026 | View on SEC |
| DEFA14A | 4/24/2026 | View on SEC |
| PRE 14A | 4/14/2026 | View on SEC |
| 8-K | 3/16/2026 | View on SEC |
| 10-K | 3/16/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ZOMDF |
| Company Name | Zomedica Corp. |
| CIK | 1684144 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | A0 |
| Phone | (734) 369-2555 |